These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7073262)

  • 1. Pharmacokinetics of fosmidomycin, a new phosphonic acid antibiotic.
    Murakawa T; Sakamoto H; Fukada S; Konishi T; Nishida M
    Antimicrob Agents Chemother; 1982 Feb; 21(2):224-30. PubMed ID: 7073262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and metabolism of fosmidomycin, a new phosphonic acid, in rats and dogs.
    Tsuchiya T; Ishibashi K; Terakawa M; Nishiyama M; Itoh N; Noguchi H
    Eur J Drug Metab Pharmacokinet; 1982; 7(1):59-64. PubMed ID: 7067725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fosmidomycin, a new phosphonic acid antibiotic. Part II: 1. Human pharmacokinetics. 2. Preliminary early phase IIa clinical studies.
    Kuemmerle HP; Murakawa T; Sakamoto H; Sato N; Konishi T; De Santis F
    Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):521-8. PubMed ID: 4066076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic evaluation of fosmidomycin, a new phosphonic acid antibiotic.
    Kuemmerle HP; Murakawa T; De Santis F
    Chemioterapia; 1987 Apr; 6(2):113-9. PubMed ID: 3594633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fosmidomycin: a new phosphonic acid antibiotic. Part I: Phase I tolerance studies.
    Kuemmerle HP; Murakawa T; Soneoka K; Konishi T
    Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):515-20. PubMed ID: 4066075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of fosfomycin.
    Kirby WM
    Chemotherapy; 1977; 23 Suppl 1():141-51. PubMed ID: 832510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of Sch 34343 in rats and dogs.
    Lin C; Loebenberg D; Chung M; Oden E; Veals J; Kim H; Lim J; Korduba C; D'Souza R; Moss E
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():219-26. PubMed ID: 4030549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of vertilmicin, a novel aminoglycoside antibiotic, in rats and dogs.
    Zhou MJ; Su MY; Wan RZ; Liu CX
    Eur J Drug Metab Pharmacokinet; 2010 Sep; 35(1-2):47-53. PubMed ID: 21495266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic comparison between fosfomycin and other phosphonic acid derivatives.
    Bergan T
    Chemotherapy; 1990; 36 Suppl 1():10-8. PubMed ID: 2085981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ceftezole, a new cephalosporin C derivative II. Distribution and excretion in parenteral administration.
    Harada Y; Matsubara S; Kakimoto M; Noto T; Nehashi T
    J Antibiot (Tokyo); 1976 Oct; 29(10):1071-82. PubMed ID: 994326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic studies of CP-74,667, a new quinolone, in laboratory animals.
    Girard D; Gootz TD; McGuirk PR
    Antimicrob Agents Chemother; 1992 Aug; 36(8):1671-6. PubMed ID: 1329625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fosfomycin kinetics after intravenous and oral administration to human volunteers.
    Goto M; Sugiyama M; Nakajima S; Yamashina H
    Antimicrob Agents Chemother; 1981 Sep; 20(3):393-7. PubMed ID: 7305325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and tissue distribution of rifametane, a new 3-azinomethyl-rifamycin derivative, in several animal species.
    Bruzzese T; Rimaroli C; Bonabello A; Mozzi G; Ajay S; Cooverj ND
    Arzneimittelforschung; 2000 Jan; 50(1):60-71. PubMed ID: 10683718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of FK027 in rats and dogs.
    Sakamoto H; Hirose T; Mine Y
    J Antibiot (Tokyo); 1985 Apr; 38(4):496-504. PubMed ID: 4008343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nocardicin A, a new monocyclic beta-lactam antibiotic VI. Absorption, excretion and tissue distribution in animals.
    Mine Y; Nonoyama S; Kojo H; Fukada S; Nishida M
    J Antibiot (Tokyo); 1977 Nov; 30(11):938-44. PubMed ID: 591460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative pharmacokinetics of BB-K8 and kanamycin in dogs and humans.
    Cabana BE; Taggart JG
    Antimicrob Agents Chemother; 1973 Apr; 3(4):478-83. PubMed ID: 4790604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs.
    Brodie RR; Mayo BC; Chasseaud LF; Hawkins DR
    Arzneimittelforschung; 1977; 27(3):593-8. PubMed ID: 577426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
    Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
    Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of a single bolus intravenous, intramuscular and subcutaneous dose of disodium fosfomycin in horses.
    Zozaya DH; Gutiérrez OL; Ocampo CL; Sumano LH
    J Vet Pharmacol Ther; 2008 Aug; 31(4):321-7. PubMed ID: 18638292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic profile of fosfomycin trometamol (Monuril).
    Segre G; Bianchi E; Cataldi A; Zannini G
    Eur Urol; 1987; 13 Suppl 1():56-63. PubMed ID: 3569380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.